宏弧商务咨询(上海)有限公司(ARC China,Inc.)
17-Aug-2009
Material Modification to Rights of Security Holders, Financia
Item 3.03. Material Modification to Rights of Security Holders
Series A Preferred Stock Securities Purchase Agreement
On August 11, 2009, Weikang Bio-Technology Group Company, Inc. (the "Company") entered into a Securities Purchase Agreement (the "Securities Purchase Agreement") with ARC China, Inc., a Shanghai corporation ("ARC").
Pursuant to the terms of the Securities Purchase Agreement, ARC agreed that it will purchase up to an aggregate of 4,768,877 Units at a purchase price of $1.75 per Unit for an aggregate purchase price of $8,345,535. Each "Unit" consists of
(i) one share of the Company's newly-designated Series A preferred stock, par value $0.01 per share ("Series A Preferred Stock"), and (ii) one-half warrant ("Warrant") to purchase one share of the Company's common stock, par value $0.00001 per share ("Common Stock"), at a price of $2.75 per share, pursuant to one or more closings on such dates and in such amounts as determined by ARC upon three days notice provided to the Company (the "Series A Purchase Transaction").
wkbt secondary 宏弧商务咨询(上海)有限公司
所有跟帖:
•
www.cowenlatitude.com china M&A
-marketreflections-
♂
(41 bytes)
()
02/14/2010 postreply
08:48:37
•
termination of the services rendered by ARC. No shares were issu
-marketreflections-
♂
(1400 bytes)
()
02/14/2010 postreply
10:17:20